Navigation Links
NeoStem, Inc. Awarded NIH Research and Research Infrastructure 'Grand Opportunities' Grant
Date:10/6/2009

NEW YORK, Oct 6 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holder of the exclusive, worldwide license to VSEL(TM) Technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that it has been awarded a grant of $108,746 for the repair of bone defects by human stem cells under the American Recovery and Reinvestment Act (RRA) of 2009 from the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) of the National Institutes of Health (NIH).

This award will fund studies to investigate the potential of very small embryonic-like stem cells to regenerate bone in an animal model. These very small embryonic-like stem cells are isolated from adults' own peripheral blood using NeoStem's proprietary isolation methods. The Company intends to undertake this work in collaboration with Dr. Russell Taichman, Professor of Dentistry, Department of Periodontics and Oral Medicine at the University of Michigan School of Dentistry. "We are honored to have been granted this award," commented Dr. Denis Rodgerson, Senior Scientist at NeoStem. "It will enable us, together with Dr. Taichman as co-principal investigator, and his colleagues, Drs. Paul Kresbach and David Kohn, to explore the significant potential for the VSEL(TM) Technology as an autologous adult stem cell-based therapy for osteoporosis and other bone diseases."

Under the Recovery Act, the NIH has established a new program entitled Research and Research Infrastructure "Grand Opportunities," also known as the "GO" grants program. This new program is designed to support large-scale research projects that accelerate critical breakthroughs, early and applied research on cutting-edg
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NeoStem, Inc. is Certified by the State of New York as a Qualified Emerging Technology Company and Notifies Investors of Possible Tax Credit of up to 20%
2. NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
3. NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Companys Audit Committee
4. NeoStem, Inc. Announces Agreement With Progenitor Cell Therapy, LLC
5. NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia
6. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show
7. Suzanne Somers To Promote Growing Importance of Storing Your Own Adult Stem Cells Under Alliance With NeoStem, Inc.
8. Morphotek(R), Inc. Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins
9. Antigen Discovery, Inc. Awarded Grant for Chlamydia Vaccine Development
10. Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis
11. Genomas Awarded $1.4 Million NIH SBIR Grant to Develop MRI+DNA Guided Biomarker System for Mental Illness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... in part) in, into or from any jurisdiction where to ... of such jurisdiction.  Shire plc ("Shire" or the ... Bloomberg article this afternoon.  Shire confirms it has held a ... being made by Shire without the prior agreement or approval ...
(Date:7/11/2014)... 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today ... acetate) for use as a once-daily adjunctive therapy for ... who are not satisfactorily controlled with conventional therapy.  APTIOM ... under 18 years of age. Epilepsy ... according to Epilepsy Canada, it affects 0.6% of the ...
(Date:7/10/2014)... Product and process impurities in biopharmaceuticals ... are often “lost in the noise,” making their ... Dr. Rowel Tobias, Senior Scientist, Protein Chemistry at ... Quality at Nanotherapeutics, Inc., to lear about a ... and quantitation while achieving the required specificity and ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 Unraveling ... closer together. The Archer Family purchased a ... within DNA, but ended up with a lifetime of ... contained within the family members’ DNA genuinely brought the ... decided to search deeper into genetic history and prior ...
Breaking Biology Technology:Shire plc - Statement re: Media Speculation 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5
... Israel and JERSEY CITY, New Jersey, December 5, Rosetta ... the,development of microRNA-based diagnostics and therapeutics, announced today,that it ... on,Thursday, December 10, from 2:30-3:35 pm EST at the ... A live audio webcast of the ...
... developing solutions based on the products of newborn fibroblasts, will be ... of the 21st Century Breakthroughs for Biomedical Research series. , ... ... a regenerative medicine company developing solutions based on the products of ...
... (Nasdaq: BCRX ) announced today that the Company ... clinical data on BCX-4208 at the 50th American Society of ... Francisco, CA from December 6-9, 2008. Forodesine HCl and ... , The schedule for BioCryst,s poster ...
Cached Biology Technology:Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference 2Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference 3Histogen Featured on Economic Report Television Series 2BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition 2BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition 3
(Date:7/11/2014)... of researchers, including scientists from the Max Planck Institute ... a major step in understanding photosynthesis, the process by ... oxygen in its atmosphere and which is therefore crucial ... , The researchers report the first direct visualization of ... step in which a specific protein complex, photosystem II, ...
(Date:7/11/2014)... Recent evidence has demonstrated that transplantation of mesenchymal stem ... rat or mouse models of Alzheimer,s disease (AD) and ... cerebral ischemia. Few studies are reported on the therapeutic ... with AD and on the effect on oxidative injury ... Yufang Yan and her team, School of Life Sciences, ...
(Date:7/11/2014)... Research and Markets has announced the addition ... Analysis Size Share Growth Trends and Forecast to 2019" ... http://photos.prnewswire.com/prnh/20130307/600769 The rising number of ... high level security in both private and public sector. ... and passwords, tokens etc. are vulnerable to attacks. Biometrics ...
Breaking Biology News(10 mins):A first direct glimpse of photosynthesis in action 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
... Listeria monocytogenes invades the body, it commandeers its host ... report published in the Journal of Biological Chemistry, a ... behind this infection technique. , The research appears as ... issue of the Journal of Biological Chemistry, an American ...
... analysis published in the Feb. 8 PNAS supports the ... , Researchers in California, Israel, and Germany have compared ... the fruit fly ?and reported that protein "wiring" connections ... This first-of-its-kind analysis of three higher level organisms published ...
... Bioengineering and Nanotechnology (IBN) has developed a novel method ... which can be used in pharmaceutical synthesis and novel ... in the leading Chemistry journal, Angewandte Chemie, and a ... , Research Scientist Dr. Yu Han and IBN Executive ...
Cached Biology News:Scientists discover that host cell lipids facilitate bacterial movement 2Examination of internal 'wiring' of yeast, worm, and fly reveals conserved circuits 2Examination of internal 'wiring' of yeast, worm, and fly reveals conserved circuits 3Examination of internal 'wiring' of yeast, worm, and fly reveals conserved circuits 4Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications 2